The healthcare market is fueling digital transformation by improving efficiency and fostering personalized care, making it an ...
9d
Zacks.com on MSNAre Investors Undervaluing Cardinal Health (CAH) Right Now?Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...
Shares of Cardinal Health Inc. CAH rallied 1.58% to $129.48 Friday, on what proved to be an all-around positive trading ...
With Neurocrine having finally shaken up treatment for a rare genetic hormone disease, Harbour BioMed’s antibody offshoot has ...
Truist Financial Corp boosted its holdings in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 29.5% during the ...
Inc., an innovative biotechnology company incubated by Harbour BioMed (HKEX: 02142), announced a strategic collaboration and ...
Cencora offers steady revenue growth from pharmaceutical distribution, benefiting from rising healthcare demand and an aging ...
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals ...
Allspring Global Investments Holdings LLC trimmed its position in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results